DalsnaFinance

Approval from Health Canada to expand Serenta Registrational Phase 3 trial in FAP and Update on Serenta Progress

Markets GlobeNewswire By GlobeNewswire 29 Jun 2026 12:30 1 min read
Approval from Health Canada to expand Serenta Registrational Phase 3 trial in FAP and Update on Serenta Progress

June 29, 2026

June 29, 2026

Read the full story on GlobeNewswire → Opens the original article on www.globenewswire.com

Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.